Teladoc(US:TDOC) ZACKS·2025-06-16 23:16Company Performance - Teladoc's stock increased by 2.33% to $7.02, outperforming the S&P 500's daily gain of 0.94% [1] - Over the past month, Teladoc's stock has decreased by 8.78%, underperforming the Medical sector's gain of 4.95% and the S&P 500's gain of 1.67% [1] Upcoming Earnings - The upcoming earnings release is expected to show an EPS of -$0.24, which is a 14.29% increase compared to the same quarter last year [2] - Revenue is projected to be $621.69 million, reflecting a 3.23% decline from the equivalent quarter last year [2] Fiscal Year Projections - For the entire fiscal year, earnings are projected at -$1.17 per share, representing an 80.07% increase from the prior year [3] - Revenue for the fiscal year is estimated at $2.52 billion, indicating a 2.12% decrease from the previous year [3] Analyst Estimates - Recent modifications to analyst estimates for Teladoc reflect short-term business trends, with positive revisions indicating analyst optimism [4] - The Zacks Rank system, which incorporates estimate changes, currently ranks Teladoc at 3 (Hold) [6] Industry Context - The Medical Services industry, part of the Medical sector, holds a Zacks Industry Rank of 67, placing it in the top 28% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]